Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • Jo茫o Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
听

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, 四色AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Exclusive partnerships

四色AV has experience of developing and supplying off-patent APIs on an exclusive basis.

Page
Read more

Customers

Full transparency for your project anywhere at any time.

Page
Read more